618
Participants
Start Date
January 31, 2002
Primary Completion Date
March 31, 2004
Study Completion Date
May 31, 2004
Darbepoetin alfa
Aranesp administered every other week SC titrated to not exceed Hb 12 g/dL
Lead Sponsor
Amgen
INDUSTRY